Cargando…
PD-1 blocking strategy for enhancing the anti-tumor effect of CAR T cells targeted CD105
PURPOS: CD105 has become a promising target of immunotherapy development for highly specific expression on the neovascular surface of most types of tumor cells. In previous studies, we constructed a CAR T cell (CD105 CAR T cell) and observed significant antitumor activity. In this study, we optimize...
Autores principales: | Wang, Xi, Lai, Zhiheng, Pang, Yanyang, Sun, Qinghui, Yang, Wenli, Wang, Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849980/ https://www.ncbi.nlm.nih.gov/pubmed/36685461 http://dx.doi.org/10.1016/j.heliyon.2022.e12688 |
Ejemplares similares
-
A novel CTLA-4 blocking strategy based on nanobody enhances the activity of dendritic cell vaccine-stimulated antitumor cytotoxic T lymphocytes
por: Yang, Wenli, et al.
Publicado: (2023) -
A CTLA-4 blocking strategy based on Nanoboby in dendritic cell-stimulated cytokine-induced killer cells enhances their anti-tumor effects
por: Wang, Wu, et al.
Publicado: (2021) -
Fully murine CD105-targeted CAR-T cells provide an immunocompetent model for CAR-T cell biology
por: Lontos, Konstantinos, et al.
Publicado: (2022) -
89723 CD105-targeted CAR T cells for the treatment of acute myeloid leukemia
por: Lontos, Konstantinos, et al.
Publicado: (2021) -
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
por: Rafiq, Sarwish, et al.
Publicado: (2018)